Opposing roles of Dnmt1 in early- and late-stage murine prostate cancer

Shannon R. Morey Kinney, Michael T. Moser, Marien Pascual, John M. Greally, Barbara A. Foster, Adam R. Karpf

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Previous studies have shown that tumor progression in the transgenic adenocarcinoma of mouse prostate (TRAMP) model is characterized by global DNA hypomethylation initiated during early-stage disease and locus-specific DNA hypermethylation occurring predominantly in late-stage disease. Here, we utilized Dnmt1 hypomorphic alleles to examine the role of Dnmt1 in normal prostate development and in prostate cancer in TRAMP. Prostate tissue morphology and differentiation status was normal in Dnmt1 hypomorphic mice, despite global DNA hypomethylation. TRAMP; Dnmt1 hypomorphic mice also displayed global DNA hypomethylation, but were characterized by altered tumor phenotype. Specifically, TRAMP; Dnmt1 hypomorphic mice exhibited slightly increased tumor incidence and significantly increased pathological progression at early ages and, conversely, displayed slightly decreased tumor incidence and significantly decreased pathological progression at advanced ages. Remarkably, hypomorphic Dnmt1 expression abrogated local and distant site macrometastases. Thus, Dnmt1 has tumor suppressor activity in early-stage prostate cancer, and oncogenic activity in late stage prostate cancer and metastasis. Consistent with the biological phenotype, epigenomic studies revealed that TRAMP; Dnmt1 hypomorphic mice show dramatically reduced CpG island and promoter DNA hypermethylation in late-stage primary tumors compared to control mice. Taken together, the data reveal a crucial role for Dnmt1 in prostate cancer and suggest that Dnmt1-targeted interventions may have utility specifically for advanced and/or metastatic prostate cancer.

Original languageEnglish (US)
Pages (from-to)4159-4174
Number of pages16
JournalMolecular and Cellular Biology
Volume30
Issue number17
DOIs
StatePublished - Sep 2010

Fingerprint

Prostate
Prostatic Neoplasms
Transgenic Mice
Adenocarcinoma
DNA
Neoplasms
Phenotype
CpG Islands
Incidence
Epigenomics
Alleles
Neoplasm Metastasis

ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology

Cite this

Morey Kinney, S. R., Moser, M. T., Pascual, M., Greally, J. M., Foster, B. A., & Karpf, A. R. (2010). Opposing roles of Dnmt1 in early- and late-stage murine prostate cancer. Molecular and Cellular Biology, 30(17), 4159-4174. https://doi.org/10.1128/MCB.00235-10

Opposing roles of Dnmt1 in early- and late-stage murine prostate cancer. / Morey Kinney, Shannon R.; Moser, Michael T.; Pascual, Marien; Greally, John M.; Foster, Barbara A.; Karpf, Adam R.

In: Molecular and Cellular Biology, Vol. 30, No. 17, 09.2010, p. 4159-4174.

Research output: Contribution to journalArticle

Morey Kinney, SR, Moser, MT, Pascual, M, Greally, JM, Foster, BA & Karpf, AR 2010, 'Opposing roles of Dnmt1 in early- and late-stage murine prostate cancer', Molecular and Cellular Biology, vol. 30, no. 17, pp. 4159-4174. https://doi.org/10.1128/MCB.00235-10
Morey Kinney, Shannon R. ; Moser, Michael T. ; Pascual, Marien ; Greally, John M. ; Foster, Barbara A. ; Karpf, Adam R. / Opposing roles of Dnmt1 in early- and late-stage murine prostate cancer. In: Molecular and Cellular Biology. 2010 ; Vol. 30, No. 17. pp. 4159-4174.
@article{70d386a42842410cb3cb4d9a30759f5f,
title = "Opposing roles of Dnmt1 in early- and late-stage murine prostate cancer",
abstract = "Previous studies have shown that tumor progression in the transgenic adenocarcinoma of mouse prostate (TRAMP) model is characterized by global DNA hypomethylation initiated during early-stage disease and locus-specific DNA hypermethylation occurring predominantly in late-stage disease. Here, we utilized Dnmt1 hypomorphic alleles to examine the role of Dnmt1 in normal prostate development and in prostate cancer in TRAMP. Prostate tissue morphology and differentiation status was normal in Dnmt1 hypomorphic mice, despite global DNA hypomethylation. TRAMP; Dnmt1 hypomorphic mice also displayed global DNA hypomethylation, but were characterized by altered tumor phenotype. Specifically, TRAMP; Dnmt1 hypomorphic mice exhibited slightly increased tumor incidence and significantly increased pathological progression at early ages and, conversely, displayed slightly decreased tumor incidence and significantly decreased pathological progression at advanced ages. Remarkably, hypomorphic Dnmt1 expression abrogated local and distant site macrometastases. Thus, Dnmt1 has tumor suppressor activity in early-stage prostate cancer, and oncogenic activity in late stage prostate cancer and metastasis. Consistent with the biological phenotype, epigenomic studies revealed that TRAMP; Dnmt1 hypomorphic mice show dramatically reduced CpG island and promoter DNA hypermethylation in late-stage primary tumors compared to control mice. Taken together, the data reveal a crucial role for Dnmt1 in prostate cancer and suggest that Dnmt1-targeted interventions may have utility specifically for advanced and/or metastatic prostate cancer.",
author = "{Morey Kinney}, {Shannon R.} and Moser, {Michael T.} and Marien Pascual and Greally, {John M.} and Foster, {Barbara A.} and Karpf, {Adam R.}",
year = "2010",
month = "9",
doi = "10.1128/MCB.00235-10",
language = "English (US)",
volume = "30",
pages = "4159--4174",
journal = "Molecular and Cellular Biology",
issn = "0270-7306",
publisher = "American Society for Microbiology",
number = "17",

}

TY - JOUR

T1 - Opposing roles of Dnmt1 in early- and late-stage murine prostate cancer

AU - Morey Kinney, Shannon R.

AU - Moser, Michael T.

AU - Pascual, Marien

AU - Greally, John M.

AU - Foster, Barbara A.

AU - Karpf, Adam R.

PY - 2010/9

Y1 - 2010/9

N2 - Previous studies have shown that tumor progression in the transgenic adenocarcinoma of mouse prostate (TRAMP) model is characterized by global DNA hypomethylation initiated during early-stage disease and locus-specific DNA hypermethylation occurring predominantly in late-stage disease. Here, we utilized Dnmt1 hypomorphic alleles to examine the role of Dnmt1 in normal prostate development and in prostate cancer in TRAMP. Prostate tissue morphology and differentiation status was normal in Dnmt1 hypomorphic mice, despite global DNA hypomethylation. TRAMP; Dnmt1 hypomorphic mice also displayed global DNA hypomethylation, but were characterized by altered tumor phenotype. Specifically, TRAMP; Dnmt1 hypomorphic mice exhibited slightly increased tumor incidence and significantly increased pathological progression at early ages and, conversely, displayed slightly decreased tumor incidence and significantly decreased pathological progression at advanced ages. Remarkably, hypomorphic Dnmt1 expression abrogated local and distant site macrometastases. Thus, Dnmt1 has tumor suppressor activity in early-stage prostate cancer, and oncogenic activity in late stage prostate cancer and metastasis. Consistent with the biological phenotype, epigenomic studies revealed that TRAMP; Dnmt1 hypomorphic mice show dramatically reduced CpG island and promoter DNA hypermethylation in late-stage primary tumors compared to control mice. Taken together, the data reveal a crucial role for Dnmt1 in prostate cancer and suggest that Dnmt1-targeted interventions may have utility specifically for advanced and/or metastatic prostate cancer.

AB - Previous studies have shown that tumor progression in the transgenic adenocarcinoma of mouse prostate (TRAMP) model is characterized by global DNA hypomethylation initiated during early-stage disease and locus-specific DNA hypermethylation occurring predominantly in late-stage disease. Here, we utilized Dnmt1 hypomorphic alleles to examine the role of Dnmt1 in normal prostate development and in prostate cancer in TRAMP. Prostate tissue morphology and differentiation status was normal in Dnmt1 hypomorphic mice, despite global DNA hypomethylation. TRAMP; Dnmt1 hypomorphic mice also displayed global DNA hypomethylation, but were characterized by altered tumor phenotype. Specifically, TRAMP; Dnmt1 hypomorphic mice exhibited slightly increased tumor incidence and significantly increased pathological progression at early ages and, conversely, displayed slightly decreased tumor incidence and significantly decreased pathological progression at advanced ages. Remarkably, hypomorphic Dnmt1 expression abrogated local and distant site macrometastases. Thus, Dnmt1 has tumor suppressor activity in early-stage prostate cancer, and oncogenic activity in late stage prostate cancer and metastasis. Consistent with the biological phenotype, epigenomic studies revealed that TRAMP; Dnmt1 hypomorphic mice show dramatically reduced CpG island and promoter DNA hypermethylation in late-stage primary tumors compared to control mice. Taken together, the data reveal a crucial role for Dnmt1 in prostate cancer and suggest that Dnmt1-targeted interventions may have utility specifically for advanced and/or metastatic prostate cancer.

UR - http://www.scopus.com/inward/record.url?scp=77956645469&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956645469&partnerID=8YFLogxK

U2 - 10.1128/MCB.00235-10

DO - 10.1128/MCB.00235-10

M3 - Article

C2 - 20584988

AN - SCOPUS:77956645469

VL - 30

SP - 4159

EP - 4174

JO - Molecular and Cellular Biology

JF - Molecular and Cellular Biology

SN - 0270-7306

IS - 17

ER -